Clinical Trials Logo

Akathisia, Drug-Induced clinical trials

View clinical trials related to Akathisia, Drug-Induced.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00693472 Terminated - Movement Disorders Clinical Trials

Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)

Start date: August 15, 2007
Phase: Phase 2
Study type: Interventional

This study is designed to evaluate the effectiveness of preladenant in the prevention (Part 1) or treatment (Part 2) of antipsychotic induced akathisia in participants with acute psychosis using the Barnes Akathisia Scale.

NCT ID: NCT00686699 Terminated - Clinical trials for Parkinsonian Disorders

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Start date: July 10, 2006
Phase: Phase 2
Study type: Interventional

This study was designed to determine if preladenant (SCH 420814, MK-3814) can reduce drug-induced involuntary movements in participants with schizophrenia or schizoaffective disorder. Participants were to be evaluated for two 14-day treatment periods with a 3-week washout period between treatment periods. The primary outcome measure, Extrapyramidal Symptom Rating Score (ESRS), was to be evaluated frequently during the treatment periods.